BRIDGES Engage | Terms and Conditions 

Effective Date: Monday May 18^th, 2025

These Terms and Conditions set forth the legally binding terms and conditions for your use of BRIDGES Engage, a digital “platform” operated by NeuroAI Inc. (“NeuroAI,” “we,” “us,” or “our”). By accessing or using the “Platform”, you (“you,” “your,” a “User”) agree to be bound by these Terms and Conditions and acknowledge that you have read and understand our Privacy Policy. By using BRIDGES Engage, you acknowledge that you have read, understood, and agreed to these Terms and Conditions.

If you do not understand and agree to these Terms and Conditions, you must immediately discontinue the use of our Platform (as defined below).

1. Overview of BRIDGES Engage

BRIDGES Engage (the “Platform”) is our proprietary digital platform. The Platform is designed to support caregivers of children with neurodevelopmental concerns by providing structured tools for data collection, organization, secure sharing, and educational resources. BRIDGES Engage is not, and is not intended to be, a medical device, diagnostic tool, or substitute for professional healthcare services. Users acknowledge and agree that they will not rely on the Platform as a replacement for professional medical advice, diagnosis, or treatment.

The Platform enables caregivers to securely document and track relevant developmental information, share data with healthcare professionals, access educational materials, and receive AI-generated insights where applicable. BRIDGES Engage consists of the following key components:

1.1 Key Components of BRIDGES Engage

• BRIDGES Connect – A structured resource hub providing caregivers with evidence-based educational materials, expert-led courses, and access to peer-support forums. Content is developed by professionals and is intended for informational purposes only, not as a replacement for professional medical advice.
• BRIDGES Passport – A secure, structured tool that allows caregivers to document and share pre-assessment data with designated healthcare providers. This feature enables the efficient transfer of information while ensuring compliance with applicable privacy laws. No AI-generated insights are provided through this component, ensuring that clinical decision-making remains independent. Users retain full control over shared data and can revoke access at any time. Data shared via BRIDGES Passport does not constitute an official medical record unless the receiving healthcare provider independently incorporates it into their system
• BRIDGES Journal – A secure behavioral and developmental tracking tool that allows caregivers to log observations, document progress, and upload media such as videos and images. This feature does not analyze or diagnose conditions but serves as a structured repository for caregiver-reported data.
• BRIDGES Allie – An AI-powered assistant designed to provide caregivers with personalized prompts, reminders, and educational insights based on their engagement with the Platform. AI-generated recommendations are strictly informational in nature and should not be interpreted as medical advice, clinical guidance, or intervention recommendations.
• BRIDGES My Child – A structured summary tool that consolidates key information regarding a child’s developmental history, behavior logs, and relevant therapy or medical records. This component is intended to help caregivers maintain a comprehensive and accessible profile that can be shared with authorized professionals at their discretion.

2. Know Your Eligibility, Responsibilities, Obligations and Rights

2.1 Eligibility Requirements

By accessing and using the Platfom you affirm, represent, and warrant that you meet all the following conditions:

1. Legal Age & Authority – and have legal authority to act as a caregiver (parent or legal guardian) for the child whose information you input, manage, or share on our Platform. Acknowledge that you may revoke access at any time, but NeuroAI cannot retroactively delete shared data from an external provider’s records.
2. Use of NeuroAI for Personal & Lawful Purposes – You will use the Platform only for its intended purpose of documenting, organizing, and securely sharing developmental information regarding a child under your care. You will not use the Platform for any commercial, unlawful, fraudulent, or unauthorized purpose.
3. Accuracy of Information – You agree to provide truthful, accurate, and current information about yourself and your child when registering for an account and using the Platform’s features. You will promptly update any changes to your personal or child-related data as necessary.
4. Compliance with Applicable Laws – You acknowledge that your use of the Platform is in accordance with applicable laws.
5. Use of Child-Related Data – You represent and guarantee that you have the legal right and authority to enter, store, and share information about the child under your care. You have full control over the selection, transmission, and revocation of your child’s shared data with healthcare professionals. You also understand that NeuroAI is not responsible for how the recipient healthcare provider handles the shared data. You accept full responsibility for verifying the recipient’s credentials before initiating data transmission. Likewise, you also agree that any disputes over shared data between you and a healthcare provider must be resolved directly with the provider. Please refer to NeuroAI’s Privacy Policy for more details. If another caregiver (e.g., co-parent, guardian) has similar rights, you acknowledge that NeuroAI is not responsible for any disputes regarding data sharing, access, accuracy, or consent among caregivers.
6. Geographic Restrictions – The Platform is intended for use only in jurisdictions where it complies with applicable laws. If you access the Platform from a location where its use would be illegal or restricted, you do so at your own risk, and NeuroAI shall bear no liability for any consequences arising from such use.

2.2 Account Security & Responsibilities

By creating an account and using the Platform, you agree to:

1. Maintain Account Confidentiality – You will keep your account credentials (e.g., username, password) confidential and secure. You will not share your login information with unauthorized individuals.
2. Accept Full Responsibility for Account Activity – Any actions taken under your account, whether by you or an authorized user (on your behalf), are your sole responsibility. NeuroAI will not be liable for any unauthorized access to your account.
3. Notify NeuroAI of Security Breaches – If you suspect unauthorized access, data breaches, or fraudulent activity involving your account, you must immediately notify NeuroAI at support@neuroai.ca.
4. Refrain from Unauthorized or Harmful Activities – You will not engage in any activity that:
   1. Attempts to gain unauthorized access to the Platform, servers, or associated networks.
   2. Interferes with, disrupts, or damages the Platform, including through hacking, malware, or unauthorized data mining.
   3. Impersonate another person or falsely represent your affiliation with an entity or another caregiver.
   4. Uploads, transmits, or distributes offensive, misleading, defamatory, infringing, or harmful content.
   5. Intentionally provide inaccurate or misleading information about your child.
   6. Uses the Platform to collect or store sensitive third-party information without proper authorization.

2.3 Third-Party Access, Responsibilities & Disputes

• Third-Party Data Access – If you share access to the child’s data with healthcare providers or other authorized users, NeuroAI is not responsible for how they handle, interpret, or use that data.
  • Users assume full responsibility for the consequences of sharing data via BRIDGES Passport. NeuroAI does not automatically share data with any third parties, including clinicians, without the caregiver’s explicit action to do so.
  • You must actively initiate data sharing via BRIDGES Passport through an affirmative action like selecting specific files to share. By using this feature, caregivers acknowledge and agree that NeuroAI acts solely as a data-sharing facilitator and expressly disclaims any responsibility to verify, audit, or influence how shared data is handled by third-party recipients.
  • NeuroAI shall not be liable for any damages arising from the use or misuse of shared data by third-party recipients.
  • Users may withdraw consent for data sharing at any time by revoking access in the Platform’s settings.
• Scope of Shared Data – By consenting to share data through BRIDGES Passport, caregivers knowingly and voluntarily authorize the transmission of:
  • Developmental history logs, as recorded in BRIDGES Journal.
  • Pre-assessment responses submitted by the caregiver.
  • Behavioral tracking logs relevant to clinical evaluation.
  • Uploaded media files (e.g., videos, images), if applicable.
  • Caregivers are responsible for ensuring that the shared data is appropriate for the intended recipient and that no unnecessary or irrelevant information is transmitted.
• Healthcare Provider Responsibilities and Limitations – Healthcare providers receiving data via BRIDGES Passport acknowledge and agree to the following limitations:
  • No Alteration of Data – The provider may not edit, modify, or alter caregiver-submitted data.
  • Independent Medical Judgment – The provider is solely responsible for assessing, interpreting, and using the data at their discretion, in accordance with applicable clinical standards.
  • No Guarantee of Clinical Use – Data shared through BRIDGES Passport is not automatically integrated into the provider’s medical records or treatment plans. The provider is not obligated to use or review shared data.
  • NeuroAI assumes no responsibility for how a healthcare provider uses, stores, or interprets the data once it has been shared by the caregiver.

2.4 Data Privacy

By accessing and using the Platform, you acknowledge, represent, and warrant that you have the legal authority to consent to, and you do hereby consent to, the collection, storage, and processing of personal and child-related data as described in our Privacy Policy.

3. AI-Generated Insights via BRIDGES Allie

BRIDGES Allie is an AI-powered assistant within the digital Platfom that provides caregivers with generalized, non-clinical information based on user engagement and logged data. The information provided by BRIDGES Allie is for informational purposes only, does not constitute professional advice of any kind, and should never be relied upon for medical, diagnostic, or therapeutic decisions advice. For more information about Bridges Allie and its associated terms and conditions, please review BRIDGES Allie Terms and Conditions.

4. Payment, Fees, and Subscriptions

4.1 Overview of Subscription Plans and Fees

BRIDGES Engage operates on a subscription-based model, with various tiers of access that may include free and paid features. By subscribing to BRIDGES Engage, you agree to the payment terms, billing cycles, and renewal policies as outlined in this section.

• Subscription Tiers – Different subscription levels may offer varying levels of access to platform features, including BRIDGES Connect, BRIDGES Passport, BRIDGES Journal, and BRIDGES Allie.
• One-Time Payments – Certain features or services within BRIDGES Engage may require a one-time payment instead of or in addition to a recurring subscription.
• Pricing and Currency – All prices are listed in Canadian Dollars (CAD) and are subject to change at NeuroAI’s sole discretion, with at least thirty (30) days’ written notice provided to subscribers in advance of any increase in fees.
• Taxes and Additional Fees – Stated prices do not include applicable taxes, transaction fees, or foreign exchange charges, which may be added at checkout based on the User’s location.

You are responsible for reviewing the most up-to-date pricing and plan details before subscribing, which are made available on the digital Platform.

4.2 Billing and Payment Terms

By subscribing to the digital Platform or purchasing any paid services, you acknowledge and agree to the following billing and payment terms:

(a) Payment Methods

• Payments may be made via credit card, debit card, digital wallets, or other accepted payment methods as specified during checkout.
• You must provide valid and accurate payment information and authorize NeuroAI (or its payment processor) to charge the payment method on file.
• If a payment is declined or fails for any reason, NeuroAI reserves the right to suspend or terminate access to paid features until payment is successfully processed.

(b) Automatic Renewal and Recurring Payments

Subscriptions are automatically renewed at the end of each billing cycle unless you cancel it before the renewal date.

• By enrolling in a subscription, you authorize NeuroAI to automatically charge the stored payment method for recurring subscription fees on a monthly or annual basis (as applicable).
• Subscription renewals will be processed at the then-current price, and any price increases will be communicated to you at least 30 days in advance.

(c) Payment Processing and Third-Party Fees

• Payments are processed through third-party payment service providers (e.g., Stripe, PayPal, or others).
• NeuroAI is not responsible for additional fees charged by third-party processors, banks, or credit card issuers, including but not limited to foreign transaction fees, overdraft fees, or currency conversion charges.

4.3 Free Trials, Discounts, and Promotional Offers

NeuroAI may, at its sole discretion, offer free trials, discounts, or promotional pricing for the digital Platform subscriptions. By participating in such offers, you agree to the following conditions:

1. Trial Periods – If a free trial is offered, Users must provide a valid payment method at the time of sign-up. Unless cancelled before the trial ends, the subscription will automatically convert to a paid plan, and the User’s payment method will be charged.
2. Limited-Time Discounts – Promotional discounts apply only for the specified duration and revert to regular pricing at the end of the promotional period.
3. Non-Transferability – Free trials and promotional offers are non-transferable, cannot be exchanged for cash, and are subject to modification or cancellation at NeuroAI’s discretion.

You are responsible for reviewing trial expiration dates and applicable terms before enrolling in any promotional offer.

4.4 Subscription Cancellation and Refund Policy

You may cancel your subscription or request refunds under the following conditions:

(a) Subscription Cancellation

• You may cancel your subscription at any time through their account settings or by contacting support@neuroai.ca.
• Cancellations will take effect at the end of the current billing period, and no further charges will be applied.
• Partial-month or partial-year refunds will not be issued, and access to paid features will continue until the end of the billing cycle.

(b) Refunds and Eligibility

NeuroAI offers refunds only under specific circumstances, including:

1. Billing Errors – If you are charged incorrectly due to an error by NeuroAI, you may request a full refund within 30 days of the transaction date.
2. Service Interruptions – While NeuroAI strives to maintain platform availability, we do not guarantee uninterrupted access to the Platform. Any refunds for service interruptions will be evaluated on a case-by-case basis at NeuroAI’s sole discretion.
3. Regulatory Compliance – Where required by applicable consumer protection laws, refunds will be issued in compliance with local regulations.

Refunds are not provided in cases where:

• The User fails to cancel before an automatic renewal date.
• The User voluntarily discontinues use of the Platform but does not request cancellation.
• The User is dissatisfied with AI-generated insights, data-sharing options, or any non-medical aspect of the Platform.

All refund requests must be submitted in writing to support@neuroai.ca, and processing times may vary based on payment provider policies.

4.5 Modifications to Subscription Terms and Fees

NeuroAI reserves the right to change pricing, billing terms, or subscription features at its sole discretion, provided that:

• You are given at least 30 days’ notice before any price increase affecting active subscriptions.
• Changes to billing cycles, automatic renewal policies, or cancellation processes will be clearly communicated via email or in-platform notifications.

Continued use of BRIDGES Engage after a notified change constitutes acceptance of the new terms. Users who do not agree with modified pricing or terms should cancel their subscription before the effective date of the changes.

4.6 User Acknowledgment and Agreement

By purchasing a subscription or making a payment for the digital platform, you:

1. Agree to the automatic renewal terms, unless you cancel before the next billing cycle.
2. Understand that all payments are final, except where explicitly stated in the refund policy.
3. Accept responsibility for managing your own billing preferences and account settings.
4. Acknowledge that NeuroAI is not responsible for third-party payment processing delays, overdraft fees, or foreign transaction charges.
5. Confirm that you have read and understood the modifications policy, including the right of NeuroAI to change subscription terms with prior notice.

5. Intellectual Property Rights

5.1 Ownership of Intellectual Property

All content (except for User-Generated Content (as defined below), features, functionalities, and materials available on or through the Platform, including but not limited to software, databases, algorithms, user interfaces, text, graphics, logos, images, videos, AI-generated models and insights, and educational resources (collectively, the “Intellectual Property”), are our exclusive property or our licensors, and are protected by applicable intellectual property laws, including copyright, trademark, trade secret, and patent laws.

By using this digital platform, you acknowledge and agree that:

1. NeuroAI retains full ownership of all Intellectual Property associated with the Platform.
2. Any feedback, suggestions, or recommendations provided by Users regarding improvements or modifications to BRIDGES Engage shall be deemed non-confidential and Users hereby grant NeuroAI a perpetual, irrevocable, worldwide, royalty-free license to use, modify, and implement such feedback without compensation, attribution, or restriction.

5.2 License to Use BRIDGES Engage – Digital Platform

Subject to compliance with these Terms and Conditions, NeuroAI grants each User a limited, non-exclusive, non-transferable, revocable, and non-sublicensable license to:

• Access and use the digital platform solely for personal, non-commercial caregiving purposes.
• Utilize AI-generated insights, educational content, and resource materials only within the scope of the Platform’s intended use.
• View, download, and print educational materials provided through BRIDGES Connect, provided that such materials are used only for personal caregiving and not for redistribution, reproduction, or commercial exploitation.

Users may not:

1. Copy, modify, distribute, sell, lease, sublicense, or commercially exploit any part of the Platform, including its content, software, AI models, or databases.
2. Reverse-engineer, decompile, disassemble, or attempt to extract source code from any part of BRIDGES Engage or its AI algorithms.
3. Use any automated tools, bots, or scraping techniques to access, analyze, or extract information from the Platform.
4. Create derivative works or adaptations based on BRIDGES Engage’s proprietary content, branding, or AI-generated insights.
5. Remove, obscure, or alter any copyright, trademark, or other proprietary notices embedded in or accompanying the Platform.

Any unauthorized use of our Intellectual Property constitutes a material breach of these Terms and Conditions and may result in immediate termination of your access and legal action.

5.3 User-Generated Content and Licensing

(a) User Ownership of Uploaded Data

You retain full ownership of any content, data, logs, videos, or other materials (“User-Generated Content” or “UGC”) that they upload or submit to BRIDGES Engage, including but not limited to:

• Developmental tracking logs recorded in BRIDGES Journal.
• Videos or images uploaded for documentation purposes.
• Written observations or caregiver notes.

(b) License Grant to NeuroAI

By uploading or submitting User-Generated Content to the digital platform, Users grant NeuroAI a worldwide, royalty-free, non-exclusive, and sublicensable license to:

• Store, process, display, and analyze UGC solely for the purpose of providing Platform functionality (e.g., enabling BRIDGES Allie to generate AI-based insights).
• Use aggregated, anonymized UGC for research, system improvement, AI model refinement, and any other business purposes, provided that such data is not personally identifiable.

Users represent and warrant that they have the legal right and necessary permissions to upload and share any User-Generated Content and that such content does not infringe on third-party rights (e.g., copyright, privacy, intellectual property, or data protection laws).

5.4 Trademarks and Branding

The BRIDGES Engage name, logo, and all related branding are trademarks of NeuroAI. You may not:

1. Use the BRIDGES Engage or other NeuroAI trademarks, logos, or branding without prior written permission.
2. Imply endorsement, partnership, or affiliation with NeuroAI without authorization.
3. Use any branding or trademarks in a manner that disparages, misrepresents, or damages the reputation of BRIDGES Engage.

Any unauthorized use of NeuroAI’s trademarks may result in legal enforcement actions, including but not limited to trademark infringement claims.

5.5 Enforcement of Intellectual Property Rights

NeuroAI reserves the right to enforce its Intellectual Property rights to the fullest extent permitted by law, including:

1. Suspension or termination of access to BRIDGES Engage for violations of this section.
2. Issuance of cease-and-desist orders to prevent unauthorized reproduction or misuse of NeuroAI’s proprietary content.
3. Legal action, including seeking damages and injunctive relief, for intellectual property infringement.

6. NeuroAI’s Responsibilities, Obligations and Rights

6.1 Suspension & Termination of Account Access

NeuroAI reserves the right, in its sole discretion and without prior notice, to suspend, restrict, or terminate your access  to the Platform if:

1. Non-Payment – If a payment fails and remains unresolved for more than 7 days, NeuroAI may suspend access to paid features until the outstanding balance is paid.
2. Violation of Terms – If you are found to be in violation of these Terms and Conditions, your account may be terminated without refund.
3. Fraudulent, illegal or Unauthorized Transactions – If NeuroAI detects unauthorized payment activity, chargeback fraud, or subscription abuse, your access to the Platform may be revoked immediately.
4. You use the Platform in a manner that could cause harm, risk, or liability to NeuroAI, other users, or third parties.
5. You engage in behavior that is abusive, harassing, or disruptive to NeuroAI staff or other Platform users.

If an account meets the criteria above to be suspended or terminated, the user will lose access to all stored data and Platform functionalities. NeuroAI shall not be liable for any resulting data loss, damages, or consequences arising from such suspension or termination. While users may request a review of suspension or termination by contacting support@neuroai.ca, NeuroAI’s decision following such review shall be final and binding.

7. Limitation of Liability

7.1 General Disclaimer of Warranties

By accessing and using the Platform, you acknowledge and agree that your use of the Platform and all associated features is provided on an “AS IS” and “AS AVAILABLE” basis without warranties of any kind, either express or implied.

To the fullest extent permitted by law, NeuroAI disclaims all warranties, representations, and conditions, including but not limited to:

1. Fitness for a Particular Purpose – The Platform does not guarantee that the tools, insights, or features provided will meet the specific needs of any User or child.
2. Merchantability – NeuroAI makes no guarantees regarding the availability, functionality, accuracy, or reliability of the Platform.
3. Non-Infringement – NeuroAI does not warrant that use of the Platform will not infringe on third-party rights.
4. Error-Free or Uninterrupted Service – NeuroAI does not guarantee that the Platform will be free from defects, viruses, service interruptions, or errors and will not be responsible for any resulting data loss or disruption.

Users acknowledge that they assume full responsibility for the risks associated with using the Platform, including reliance on AI-generated insights, caregiver-submitted data, and shared pre-assessment information.

7.2 Limitation of Liability

To the fullest extent permitted by law, NeuroAI, its affiliates, directors, officers, employees, contractors, agents, licensors, service providers, and successors shall not be liable for:

(a) Direct or Indirect Damages

• Any loss of data, revenue, business, profits, goodwill, or savings resulting from the use of, or inability to use, BRIDGES Engage.
• Any costs of procuring substitute services due to Platform unavailability.
• Any service interruptions, delays, or errors related to system maintenance, third-party dependencies, cyberattacks, or force majeure events.

(b) Consequential, Incidental, or Special Damages

NeuroAI shall not be liable for any indirect, incidental, special, punitive, or consequential damages arising from:

• User reliance on AI-generated insights from BRIDGES Allie.
• Misinterpretation, inaccuracy, or incompleteness of data logged within BRIDGES Journal or shared via BRIDGES Passport.

Decisions made by caregivers or healthcare providers based on Platform-generated reports or AI recommendations.

(c) Unauthorized Access and Security Breaches

While NeuroAI implements industry-standard security measures, we do not guarantee that unauthorized third parties will never be able to circumvent our security protections. Users agree that NeuroAI is not responsible for:

• Unauthorized access to or modification of User data resulting from hacking, malware, phishing attacks, or credential theft.
• Breach of data confidentiality by third-party healthcare providers who receive User-shared information via BRIDGES Passport.

7.3 Data Sharing Risks and User Responsibility

(a) User Responsibility for Shared Data

• Users voluntarily share pre-assessment data through BRIDGES Passport and accept full responsibility for verifying the credentials of recipient healthcare providers.
• NeuroAI is not liable for how third-party clinicians or institutions use, store, or interpret shared data.

(b) No Liability for Third-Party Misuse

NeuroAI does not control and is not responsible for:

• Misuse, misinterpretation, or unauthorized use of shared caregiver data by healthcare providers.
• Data retention policies of third parties, including whether healthcare providers delete shared records upon request.

Users are advised to review provider policies before sharing data and to exercise caution when transmitting sensitive information.

7.4 Force Majeure

NeuroAI shall not be held responsible for any failure or delay in performance due to events beyond its reasonable control, including but not limited to:

• Acts of God, natural disasters, pandemics, or extreme weather events.
• Cyberattacks, power failures, or internet disruptions affecting Platform access.
• Government regulations, compliance changes, or legal restrictions impacting Platform operations.

If a force majeure event materially impacts the digital Platform services, NeuroAI reserves the right to suspend, modify, or discontinue access without liability.

7.5 Indemnification by Users

By using “the Platform”, Users agree to defend, indemnify, and hold harmless NeuroAI, its affiliates, directors, officers, employees, agents, and licensors from and against any and all claims, liabilities, damages, losses, costs or expenses (including reasonable legal fees and disbursements) arising from:

1. User-submitted content (e.g., inaccurate caregiver logs, inappropriate media uploads).
2. Misuse or unauthorized access to the “Platform” in violation of these Terms and Conditions.
3. Third-party disputes arising from User interactions with healthcare providers through BRIDGES Passport.

Users waive any claims against NeuroAI for any liability arising from User actions or shared data.

7.6 Maximum Liability Cap

To the fullest extent permitted by law, the total aggregate liability of NeuroAI for any claims arising under these Terms and Conditions shall not exceed the total amount paid by the User for the digital Platform services in the past 12 months, or $100 CAD, whichever is greater.

If a jurisdiction does not allow the exclusion or limitation of certain liabilities, the above limitations shall apply only to the fullest extent permitted by law.

8. Modifications to These Terms

8.1 Right to Modify Terms

NeuroAI reserves the right, at our sole discretion, to modify these Terms and Conditions at any time to reflect changes in:

• Applicable laws, regulations, or industry standards impacting the Platform;
• New features, functionalities, or services introduced to BRIDGES Engage;
• Operational requirements, security policies, or technology updates;
• Subscription plans, pricing structures, or payment processing policies; or
• Any other business, technical, or legal considerations deemed necessary by NeuroAI.

All modifications will be effective upon posting unless otherwise specified in the notice provided to Users.

8.2 User Notification and Acceptance of Changes

(a) Notification of Changes

NeuroAI will provide reasonable notice of any material modifications to the Terms and Conditions by:

• Posting an updated version of the Terms and Conditions on the BRIDGES Engage website and within the Platform;
• Sending a notification via email to register Users (where required by applicable law); and/or
• Providing an in-platform alert or pop-up requiring acknowledgment before continued access to BRIDGES Engage.

For minor or non-material changes (e.g., clarifications, formatting updates, technical adjustments), NeuroAI may update these Terms and Conditions without prior notice. Users are responsible for periodically reviewing the most current version of the Terms and Conditions.

(b) Continued Use as Acceptance

By continuing to access or use BRIDGES Engage after the effective date of any modifications, Users agree to be bound by the revised Terms and Conditions.

If a User does not agree with the modified Terms and Conditions, their sole remedy is to:

1. Discontinue use of BRIDGES Engage, and
2. Cancel any active subscriptions before the renewal date to avoid further charges.

NeuroAI is not liable for any damages, loss of access, or account termination resulting from a user’s refusal to accept the modified Terms and Conditions.

8.3 Changes to Subscription Pricing and Fees

NeuroAI reserves the right to modify, increase, or restructure subscription fees, payment terms, or billing cycles at any time.

• Any changes to pricing for existing subscriptions will be communicated at least 30 days in advance via email and/or in-platform notifications.
• Users who do not cancel before the next billing cycle will be deemed to have accepted the new pricing.
• If required by law, NeuroAI may obtain explicit User consent before implementing material pricing changes.

NeuroAI does not issue refunds for pricing changes that take effect after a User’s renewal date.

8.4 Dispute Resolution for Changes

If a User disputes any modifications to these Terms and Conditions, the User agrees to:

1. Contact NeuroAI Support at support@neuroai.ca within 30 days of receiving notice to attempt a resolution.
2. If unresolved, follow the Dispute Resolution Process outlined in Section 10 (Governing Law and Dispute Resolution) of these Terms and Conditions.

Failure to raise a dispute within the designated period constitutes acceptance of the modified Terms and Conditions.

8.5 No Retroactive Changes

Modifications to these Terms and Conditions will not apply retroactively unless:

• Required by law or regulatory mandate, or
• Expressly agreed upon by both the User and NeuroAI in a separate written agreement.

Changes affecting existing legal rights, dispute resolution procedures, or User data privacy will be implemented only after appropriate notice and compliance with applicable consumer protection laws.

8.6 User Acknowledgment and Agreement

By using the Platform, you:

1. Acknowledge that NeuroAI may modify these Terms and Conditions at its discretion, subject to applicable legal requirements.
2. Agree to review and comply with the most current version of the Terms and Conditions posted on the Platform.
3. Understand that continued use constitutes acceptance of any modifications, and refusal to accept modifications requires discontinuation of use.
4. Acknowledge that pricing, subscriptions, and feature availability may change without liability to NeuroAI.
5. Agree that NeuroAI has no obligation to maintain prior versions of the Terms and Conditions after modifications take effect.

9. Governing Law and Dispute Resolution

9.1 Governing Law

These Terms and Conditions and any dispute, claim, or controversy arising out of, related to, or in connection with the use of BRIDGES Engage (the “Platform”), including its interpretation, validity, enforceability, and performance, shall be governed by and construed in accordance with the laws of:

• New Brunswick, Canada, without regard to its conflict of law principles.
• Federal laws of Canada, where applicable.

If a provision of these Terms and Conditions is determined to be invalid or unenforceable under applicable law, the remaining provisions shall remain in full force and effect.

Users agree that they are solely responsible for ensuring compliance with any local, national, or international laws that may apply to their use of BRIDGES Engage.

9.2 Mandatory Dispute Resolution Process

(a) Initial Informal Resolution

Before initiating formal legal proceedings, both NeuroAI and the User agree to attempt good faith informal resolution of any dispute.

• The party raising the dispute must submit a written notice to the other party detailing the nature of the claim, facts supporting the dispute, and the requested resolution.
• Users must send dispute notices to trust@neuroai.ca or through a registered mail to NeuroAI’s registered office in New Brunswick 30 days of becoming aware of the issue.
• NeuroAI will respond within 30 days of receipt, engaging in informal discussions to resolve the dispute.

Failure to participate in good faith in the informal resolution process may be considered by an arbitrator or court when determining the resolution of a dispute.

9.3 Binding Arbitration Agreement

(a) Agreement to Arbitrate

If an informal resolution cannot be reached within 60 days, both parties agree that any dispute, controversy, or claim shall be exclusively resolved through binding arbitration, except for claims that qualify for small claims court as described below.

By using BRIDGES Engage, the User agrees to arbitration as the primary method for resolving disputes, subject to applicable law and retaining any non-waivable rights under New Brunswick and Canadian law.

(b) Arbitration Procedure

• The arbitration shall be conducted by a neutral arbitrator in accordance with the Arbitration Act (New Brunswick).
• The arbitration shall be held in Fredericton, New Brunswick, unless both parties agree to an alternative location or virtual arbitration.
• Arbitration shall be conducted in the English language unless otherwise agreed.
• The arbitrator shall have exclusive authority to determine all matters within the scope of these Terms and Conditions, including arbitrability and interpretation, subject to applicable law.

(c) Costs of Arbitration

• Each party shall bear its own legal costs, legal fees, and expenses, unless the arbitrator determines that awarding costs is appropriate under the governing arbitration rules.

(d) Small Claims Court Exception

Notwithstanding the above arbitration agreement, either party may seek to resolve disputes in small claims court if the claim:

• Falls within the jurisdictional monetary limit of the New Brunswick Small Claims Courts; and
• Seeks only monetary damages and does not involve injunctive or equitable relief.

Filing a claim in small claims court does not waive either party’s obligation to arbitrate all other disputes.

9.4 Class Action Waiver

Users agree that any dispute resolution shall be conducted on an individual basis only.

• No Class Actions – Users waive the right to bring or participate in any class action, collective action, private attorney general action, or other representative proceeding against NeuroAI.
• No Consolidation of Claims – Arbitration or small claims proceedings must be conducted on a one-on-one basis, and claims may not be combined with other Users’ claims.

If this class action waiver is found to be unenforceable in any jurisdiction, the entire arbitration agreement shall be null and void with respect to that jurisdiction, and disputes shall be resolved in the Court of King’s Bench of New Brunswick or other court of competent jurisdiction.

9.5 Injunctive and Equitable Relief

Notwithstanding any provision in these Terms and Conditions, NeuroAI retains the right to seek injunctive or equitable relief in:

• Any court of competent jurisdiction, where necessary to protect its Intellectual Property, confidential information, or proprietary rights.
• Cases involving actual or threatened violations of intellectual property rights, misuse of AI-generated insights, fraud, or security breaches.

This means NeuroAI may bypass arbitration for claims seeking a court-ordered remedy (such as stopping the misuse of its proprietary content).

9.6 Survival of Dispute Resolution Provisions

The provisions in this Governing Law and Dispute Resolution section shall survive:

• Termination of a User’s account;
• Discontinuation of the BRIDGES Engage platform; and
• Any expiration of these Terms and Conditions.

9.7 User Acknowledgment and Agreement

By using BRIDGES Engage, you:

1. Acknowledge that disputes shall be resolved through binding arbitration, not court litigation.
2. Waive the right to class actions or representative lawsuits.
3. Agree to first attempt informal dispute resolution before initiating arbitration or small claims proceedings.
4. Understand that claims for injunctive or equitable relief related to NeuroAI’s intellectual property may still be brought in court.
5. Accept that you are bound by this dispute resolution clause, even if you discontinue use of the Platform.

10. Contact Information

For support, inquiries, or to exercise your data rights, contact:

NeuroAI Support – support@neuroai.ca

Legal Support – trust@neuroai.ca